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Abstract
Primary tumors of serosal surfaces are uncommon in veterinary medicine. Mesothelial neoplasms can be
benign or malignant, and are classified as predominantly epitheloid, mixed (biphasic), or fibrous (spindle cell,
fibrosarcomatous), with fibrous mesotheliomas reported least in domestic species. A 9-year-old Domestic
Shorthair cat presented on emergency with a brief history of weakness and lethargy. On presentation, the cat
was semicomatose, hypothermic, and hypotensive with a markedly distended abdomen. Approximately 1 liter
of serosanguineous fluid was removed via abdominocentesis. Diagnostic imaging and cytologic evaluation of
fine-needle aspirates were suggestive of neoplasia, and the cat was subsequently euthanized. At necropsy, the
omentum was contracted cranially into an irregular lobular mass that surrounded the stomach and proximal
intestinal tract, and focally infiltrated the spleen. Both visceral and parietal peritoneal surfaces were thickened
and contained off-white friable material and occasionally firm fibrous plaques. Microscopically, serosal
surfaces were expanded by neoplastic spindle cells, which were often accompanied by moderate to abundant
fibrous stroma. Neoplastic cells had varying degrees of immunoreactivity for cytokeratin, vimentin, desmin,
and smooth muscle actin, which was consistent with the diagnosis of mesothelioma.
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A 4.5-kg female spayed Domestic Shorthair cat presented to 
the Iowa State University Emergency Service (Ames, Iowa) 
with a 1-day history of anorexia, adipsia, weakness, and 
lethargy. The patient was not current on rabies or feline viral 
rhinotracheitis, calicivirus, and panleukopenia vaccinations 
and was housed outdoor and indoor. The owners noted the cat 
was severely ataxic the evening prior to presentation, and that 
she had vomited the morning of presentation.
On presentation, the patient was semicomatose. Physical 
examination revealed severe hypothermia (34.3°C), bradycar-
dia (137 beats/min), and eupnea (16 breaths/min). She was 
10–12% dehydrated and severely hypotensive, with a systolic 
blood pressure of 50 mmHg and weak, thready femoral pulses. 
The abdomen was severely distended and symmetrically 
enlarged.
An abdominocentesis was performed, and 1,030 ml of 
serosanguineous fluid was removed. Fluid analysis revealed 
glucose of 307 mg/dl, lactate of 9.1 mmol/l, and specific 
gravity of 1.028. Initial blood work demonstrated a glucose 
of 244 mg/dl (reference [ref.] interval: 70–135 mg/dl), lac-
tate of 1.7 mmol/l (ref. interval: <2.5 mmol/l), packed cell 
volume of 40% (ref. interval: 30–45%), total solids of 7.2 g/dl 
(ref. interval: 6.1-8.0 g/dl), and blood urea nitrogen (BUN) 
reagent stripa of 50–80 mg/dl (ref. interval: 5–15 mg/dl). 
After fluid therapy, additional blood was drawn for a 
complete blood cell count (CBC), serum biochemistry, 
Feline leukemia virus (FeLV) antigen testing,b and Feline 
immunodeficiency virus (FIV) antibody testing.b The CBC 
demonstrated leukopenia of 3.74 (ref. interval: 5.5–19.5 × 
103/µl), hematocrit of 29.9% (ref. interval: 30–45%), lym-
phopenia of 0.15 (ref. interval: 1.5–7.0 × 103/µl), and red 
blood cell distribution width of 13.4% (ref. interval: 15–22%). 
Serum biochemistry showed hyponatremia of 127 mEq/l (ref. 
interval: 155–165 mEq/l), hypochloremia of 93 mEq/l 
(ref. interval: 123–131 mEq/l), hypocalcemia of 6.0 mg/dl 
(ref. interval: 8.5–11.2 mg/dl), hypermagnesemia of 6.15 
mg/dl (ref. interval: 1.95–3.04 mg/dl), azotemia (elevated 
BUN) of 102.9 mg/dl (ref. interval: 15–35 mg/dl), hypergly-
cemia of 243 mg/dl (ref. interval: 70–135 mg/dl), hypopro-
teinemia of 4.6 g/dl (ref. interval: 6.1–8.0 g/dl), and increased 
anion gap of 18 (ref. interval: 12–16). Enzyme-linked immu-
nosorbent assay testing for FeLV and FIV were negative.
The patient was stabilized, and abdominal radiographs 
were taken, which demonstrated a moderate decrease in 
serosal demarcation throughout the peritoneal space. This 
was most prominent within the middle, ventral aspect of the 
abdomen. Also, there was a mottled soft tissue and/or fluid 
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and gas opacity extending cranially from the middle, ventral 
abdomen. Remaining intra-abdominal structures were unable 
to be assessed due to border effacement of their margins. 
Figure 1. Mesothelioma of the peritoneum; cat. The omentum is 
contracted cranially into a multinodular mass (arrows). Multifocal 
fibrous plaques can be seen on the reflected abdominal wall 
(asterisks), and there is a small amount of serosanguineous fluid in 
the peritoneal cavity.
Abdominal ultrasonography revealed free fluid throughout 
the abdomen, and a markedly nodular, and hyperechoic omen-
tal curtain. In certain regions, the omentum was heterogenous 
with less echoic central tissue surrounded by more hypere-
choic areas. Radiographic conclusions were possible carci-
nomatosis or sarcomatosis. Other considerations included 
infectious or inflammatory diseases such as feline infectious 
peritonitis or fungal infection.
Transabdominal fine-needle aspirates were taken of the 
irregularly thickened omentum at 3 sites and submitted for 
cytology. Large, atypical, rounded cells with fine vacuoles 
were noted in all cytology samples. Single, bi-, and multinu-
cleated cells were observed with a large variability and irreg-
ularly shaped nucleoli. These cells could not be differentiated 
from macrophages, endothelial or epithelial cells. Differential 
diagnoses included neoplasia and granulomatous inflammation. 
Possible neoplasms included adenocarcinoma, mesothelioma, 
or hemangiosarcoma.
Due to poor prognosis, the cat was euthanized, and a nec-
ropsy was performed. On gross examination, the omentum was 
Figure 2. Omentum; cat. Peritoneal fibrosarcomatous mesothelioma characterized by marked expansion of the peritoneum by neoplastic 
spindled cells and moderate to abundant fibrous connective tissue. Bands of neoplastic cells multifocally extend into underlying adipose 
tissue. Hematoxylin and eosin. Figure 3. Omentum; cat. Higher magnification of neoplastic mesenchymal cells in Figure 2. Neoplastic 
cells are arranged in streams with moderate fibrous connective tissue stroma. A mitotic figure (arrow) is present. Hematoxylin and eosin. 
Bar = 20 µm. Figure 4. Peritoneal fibrosarcomatous mesothelioma; cat. The vast majority of neoplastic cells exhibited strong cytoplasmic 
immunoreactivity for vimentin. Bar = 20 µm. Figure 5. Peritoneal fibrosarcomatous mesothelioma; cat. Fewer neoplastic cells exhibited 
moderate cytoplasmic immunoreactivity for cytokeratin. Bar = 20 µm.
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contracted cranially forming a large, irregular, firm, tan, multi-
nodular mass that was approximately 10 cm in diameter 
(Fig. 1). The mass surrounded the intestinal tract, includ-
ing the stomach, and was attached to the spleen. The 
spleen was apparently focally infiltrated by the mass, and 
the capsular surface was diffusely covered by off-white semi-
friable material. The peritoneal cavity contained about 30 ml 
of serosanguineous fluid, and the parietal peritoneum was 
diffusely thickened with multifocal, firm, white to tan 
plaques ranging from 2 to 6 cm in size. The liver was dif-
fusely pale yellow in color, with a focal accumulation of 
similar off-white material on the capsular surface.
Specimens of multiple tissues were fixed in 10% neutral 
buffered formalin, embedded in paraffin, sectioned, and 
stained with hematoxylin and eosin. Sections of omentum 
were also labeled with monoclonal antibodies against 
vimentin,c cytokeratin,d desmin,e smooth muscle actin,f and 
S-100.g Histologically, the omentum was superficially 
expanded by an unencapsulated and moderately well-demar-
cated neoplasm composed of spindled cells (Fig. 2), which 
occasionally infiltrated deep into residual omental adipose 
tissue. Neoplastic cells were arranged in streams and bun-
dles, and were supported by moderate to marked amounts of 
fibrovascular to densely fibrous stroma (Fig. 3). Neoplastic 
cells had variably distinct cell borders and contained small 
amounts of fibrillar eosinophilic cytoplasm and round to 
elongate nuclei with finely stippled chromatin and 1–2 
prominent nucleoli. There was moderate anisocytosis and 
anisokaryosis, and the mitotic rate was high (2–3 per 400× 
field) with occasional bizarre mitoses. The peritoneum of the 
abdominal wall was markedly expanded by similar neoplas-
tic cells and abundant fibrous tissue, which occasionally 
superficially invaded underlying skeletal muscle. The capsu-
lar surface of the spleen was lined by similar neoplastic cells 
and stroma, which focally infiltrated and effaced splenic 
parenchyma. Neoplastic cells were also present on the peri-
toneal surfaces of the liver, adrenal glands, stomach, small 
intestine, and urinary bladder. Neoplastic cells were strongly 
positive for vimentin (Fig. 4) and moderately positive for 
cytokeratin (Fig. 5). Additionally, there was weak to moder-
ate labeling for desmin, and strong and relatively widespread 
labeling for smooth muscle actin. Immunohistochemistry for 
S-100 was negative. Masson trichrome stain revealed fine 
fibrils and broad bundles of collagenous stroma supporting 
and separating neoplastic cells. Prussian blue staining for 
iron (ferruginous bodies) was negative. Appropriate positive 
and negative control tissues were included in all labeling 
procedures.
In consideration of the gross, microscopic, and immuno-
histochemistry findings, the favored diagnosis in the present 
case is fibrosarcomatous mesothelioma. Differential diagnoses 
based on histology were metastatic carcinoma (sarcomatoid) 
or sarcoma (e.g., intestinal leiomyosarcoma), and liposar-
coma. A primary neoplasm was not identified, making 
metastatic carcinoma or sarcoma less likely. The presence 
of adipocytes entrapped by the neoplastic spindle cell pop-
ulation, especially within the omentum, prompted the con-
sideration of liposarcoma. However, the histomorphology of 
the tumor was inconsistent with that generally reported for 
liposarcoma (sheets of round to polygonal cells, which usu-
ally contain diagnostic intracytoplasmic lipid vacuoles), as 
were the immunohistochemistry results. Liposarcomas are 
cytokeratin negative and often S-100 positive.4 Distinguishing 
features of the neoplasm in the current case include the distri-
bution of neoplastic cells along serosal surfaces and expres-
sion of both vimentin and cytokeratin. Additionally, while 
desmin and smooth muscle actin are not considered discrimi-
natory markers for sarcomatous mesothelioma, their expres-
sion pattern as reported herein has been described in human 
sarcomatous mesotheliomas.9
The pericardial, pleural, and peritoneal cavities, internal 
organs, and tunica vaginalis of the testes are lined by a mono-
layer of cells termed the mesothelium. The mesothelium 
functions to provide protection from physical damage and 
invading pathogens. In addition, this nonadhesive layer 
plays a major role in fluid and cell transportation, surfactant 
secretion, tumor cell adhesion, antigen presentation, inflam-
mation, and tissue repair.11,16 These mesenchymal deriva-
tives differentiate from a rounded or cuboidal form to an 
elongated, flattened, squamous shape.10 Cuboidal cells may 
still be observed during an activated or increased metabolic 
state (e.g., peritonitis) and are typically located in sampling 
grounds such as lymphatic lacunae or “milky spots” on the 
omentum.11,16 Mesothelial cells regenerate from multipotent 
precursor cells located in the submesothelium,11 and typi-
cally express both mesenchymal and epithelial intermediate 
filaments (vimentin and desmin, and cytokeratins, respec-
tively) permitting a phenotypic duality. It is expression of 
these markers that allows differentiation of malignant 
mesothelial disease from other malignant processes, such as 
carcinomatosis.
Three primary histologic patterns of mesothelioma are 
described: epithelioid, sarcomatoid (spindle cell, fibrous, fibro-
sarcomatous), and mixed (biphasic).7 Malignant mesothelio-
mas (MM) are rare in all species, but occur most rarely in 
cats. Felines usually present with spontaneous and idiopathic 
forms in adulthood.2 Malignant mesothelioma has been 
associated with many suggested predisposing factors such 
as past radiation exposure, chemical exposure, genetic predis-
position, and asbestos and non-asbestos fibers.15
Malignant mesothelioma is essentially a diagnosis of exclu-
sion and is based on integration of history, clinical findings, 
imaging, and morphologic studies such as gross pathology, 
histology, immunohistochemistry, and electron micros-
copy. Effusions are a common clinical finding due to exuda-
tion from obstructed lymphatics and tumor surfaces.15 
Advanced imaging such as abdominal ultrasound is usually 
not helpful except late in the disease process. Computed 
tomography has been used to show pulmonary nodules asso-
ciated with thoracic effusion, but also has limited value.15
596 Heerkens et al.
Cytology is typically nondiagnostic in itself even though 
malignant mesothelial cells will exfoliate into effusions. The 
challenge in diagnosing MM with cytology lies in discerning 
reactive hypertrophic mesothelial cells from malignant cells 
due to overlapping cytologic features.15 A recent human 
study used logistic regression analysis to determine differen-
tiating cytologic features that can distinguish between reactive 
mesothelial proliferation, adenocarcinoma, and MM cells in 
effusion samples.3 Ultimately, 3 cytologic features were 
determined to distinguish MM from adenocarcinoma: giant 
atypical mesothelial cells, acinar structures, and nuclear 
pleomorphism with the latter two being characteristics of 
adenocarcinoma. In addition, 3 features were determined to 
distinguish MM from benign (reactive) mesothelial proliferation: 
cell ball formation, cell-in-cell engulfment, and monolayer 
cell aggregates with the latter being characteristic for benign 
mesothelial proliferation. Even with these criteria and ade-
quate cytologic samples, a definitive diagnosis was made in 
only approximately 66% of cases.3
Typical postmortem findings of MM in domestic animals 
include multiple sessile or pedunculated nodules ranging in 
size from a few millimeters to >5 cm in diameter, or villous 
projections, arising from a thickened mesentery or serosal sur-
face. Masses may eventually coalesce to encase organs in 
tumor tissue, as with the omentum in the current case. Prior 
reports of peritoneal mesothelioma in cats describe a gross 
presentation of multiple nodules associated with serosal sur-
faces.1,2,8,12 In the case reported herein, the gross presentation 
of a contracted omental mass accompanied by a thickened 
peritoneum with fibrous plaques is unique, and likely attribut-
able to the distinct morphology of the tumor. Additionally, 
feline peritoneal mesotheliomas reported to date have been 
characterized histologically as epithelioid or biphasic, not 
fibrous or fibrosarcomatous.
Mesotheliomas in domestic species were once thought to 
rarely metastasize and to have limited invasive growth. A 
recent study examining both pleural and peritoneal mesothe-
liomas in the cat reported metastasis in 6 of 10 cases reviewed.2
Definitive diagnosis of MM via histology can be challeng-
ing. Depending on the morphology of the neoplasm, common 
differential diagnoses for mesothelioma include carcinoma or 
adenocarcinoma, reactive mesothelial cell proliferation, meta-
static squamous cell carcinoma, fibrosarcoma, malignant 
fibrous histiocytoma, and reactive cellular fibrosis. In veteri-
nary medicine, common secondary histologic patterns of epi-
thelioid mesothelioma include papillary, tubular, tubulopapillary, 
and solid.6 Fibrous or fibrosarcomatous forms of mesothelioma, 
the least common form in animals, consist of predominantly 
spindle-shaped cells supported by a fibrous connective tissue 
stroma, as in the present case. Biphasic mesotheliomas contain 
both epithelioid and spindle-shaped cells, and are relatively rare 
with regard to peritoneal mesotheliomas. This is important, as 
biphasic patterns are less amenable to treatment and carry a 
grave prognosis compared to other forms.7
Immunohistochemical staining is useful in ruling out 
other diseases, but currently there are no cellular markers 
specific for mesothelial cells. Instead, immunohistochemistry 
is based on panels of positive (commonly present) and nega-
tive (commonly absent) markers for mesothelioma.14 In cats, 
1 study determined vimentin and broad spectrum cytokeratin 
(CK) expression to be a constant feature of all mesotheliomas, 
whether epithelial or spindle-cell type.2 This study also con-
cluded that a secondary antibody panel containing HBME-1 
(a monoclonal antibody that recognizes an uncharacterized 
antigen on mesothelial microvilli), e-cadherin, carcinoem-
bryonic, CK5/6, and CKAE1/AE3 markers are potentially 
valuable in further differentiating feline fibrosarcomatous 
mesothelioma from other forms. Neoplastic cells in the tumor 
reported herein were strongly positive for vimentin and inter-
mediately positive for cytokeratin.
Ultrastructural features are thought to be useful only 
for diagnosing well-differentiated epithelial mesothelio-
mas as opposed to fibrosarcomatous mesotheliomas.5 
Characteristic electron microscopy findings include long, 
slender microvilli present on all surfaces, perinuclear 
tonofilaments, and desmosomes. In addition, 1 case of 
peritoneal mesothelioma in a cat demonstrated psam-
moma bodies via electron microscopy.1 Electron micros-
copy was not performed in the current case. New 
diagnostics are on the horizon and include microarray 
studies using gene expression ratio techniques to both 
confirm diagnosis and prognostication.15
Treatments available may include intracavitary and/or sys-
temic chemotherapeutics, such as carboplatin and doxorubicin 
or mitoxantrone, respectively. Radical resection, radiation, and 
clinical supportive care are additional therapies.13 In fact, intra-
cavitary carboplatin and piroxicam have been shown to decrease 
effusion production in the case of one cat.13 Palliative therapies 
in nonsurgical human patients may include vinorelbine (single 
agent chemotherapy) and pemetrexed (a multi-targeted antifo-
late) combined with cisplatin. Numerous cytokines (e.g., IL-2, 
alph-2b) have been proven to be beneficial in human bulky dis-
ease. Most recently, growth factor receptor inhibitors (e.g., bev-
acizumab, gefitinib) are under investigation.15 Median survival 
times have not been officially reported due to the low rate of 
occurrence of the disease and because most animals are eutha-
nized at the time of diagnosis.15
In conclusion, a case of peritoneal fibrosarcomatous 
mesothelioma in a cat is presented in the current report. 
Malignant mesothelioma is a rare yet highly lethal neoplasia 
that is complex and difficult to diagnose. Although many 
diagnostic tools and experimental treatments have been 
implemented in human trials, veterinary medicine is in 
need of species-specific information. The present 
report adds to the veterinary literature regarding meso-
thelioma in animal species, and serves to evaluate feline 
mesotheliomas to better enhance diagnostics, prognostica-
tion, and therapeutics.
 Peritoneal fibrosarcomatous mesothelioma in a cat 597
Acknowledgements
The authors thank Dr. M. Curtis for review of the manuscript, 
Dr. D. L’Heureux for radiographic interpretation, and D. Moore for 
technical assistance. Mention of trade names or commercial products 
in this report is solely for the purpose of providing specific informa-
tion and does not imply recommendation or endorsement by the 
U.S. Department of Agriculture.
Sources and manufacturers
a. Azostix, Siemens Healthcare Diagnostics Inc., Tarrytown, 
NY.
b. SNAP FIV/FeLV, IDEXX Laboratories Inc., Westbrook, ME.
c. Mouse anti-vimentin, MNF116, Dako North America Inc., 
Carpinteria, CA.
d. Mouse anti-human cytokeratin, V9, Dako North America Inc., 
Carpinteria, CA.
e. Mouse anti-desmin, Dako North America Inc., Carpinteria, CA.
f. Mouse anti-smooth muscle actin, BioGenex Laboratories Inc., 
San Ramon, CA.
g. Rabbit anti-S-100, Dako North America Inc., Carpinteria, CA.
Declaration of conflicting interests
The authors declared that they had no conflicts of interest with 
respect to their authorship or the publication of this article. 
Funding
The authors declared that they received no financial support for 
their research and/or authorship of this article.
References
 1. Akiyama K, Suzuki Y: 1982, A case of feline peritoneal meso-
thelioma with psammoma bodies. Nippon Juigaku Zasshi 
44:975–979.
 2. Bacci B, Morandi F, De Meo M, Marcato PS: 2006, Ten cases 
of feline mesothelioma: an immunohistochemical and ultra-
structural study. J Comp Pathol 134:347–354.
3. Cakir E, Demirag F, Aydin M, Unsal E: 2009, Cytopathologic dif-
ferential diagnosis of malignant mesothelioma, adenocarcinoma 
and reactive mesothelial cells: a logistic regression analysis. Diagn 
Cytopathol 37:4–10.
 4. Cocchia D, Lauriola L, Stolfi VM, et al.: 1983, S-100 antigen 
labels neoplastic cells in liposarcoma and cartilaginous tumours. 
Virchows Arch A Pathol Anat Histopathol 402:139–145.
 5. Hammar SP: 2006, Macroscopic, histologic, histochemical, 
immunohistochemical, and ultrastructural features of mesothe-
lioma. Ultrastruct Pathol 30:3–17.
 6. Head KW, Cullen JM, Dubielzig RR, et al., eds.: 2003, Tumors 
of serosal surfaces. In: Histologic classification of tumors of the 
alimentary system of domestic animals, pp. 144–147. Armed 
Forces Institute of Pathology, Washington, DC.
 7. Head KW, Else RW, Dubielzig RR: 2002, Tumors of serosal 
surfaces. In: Tumors of domestic animals, ed. Meuten DJ, 4th 
ed., pp. 477–478. Iowa State Press, Ames, IA.
 8. Kobayashi Y, Usuda H, Ochiai K, Itakura C: 1994, Malignant 
mesothelioma with metastases and mast cell leukaemia in a cat. 
J Comp Pathol 111:453–458.
 9. Kushitani K, Takeshima Y, Amatya VJ, et al.: 2008, Differential diag-
nosis of sarcomatoid mesothelioma from true sarcoma and sarcoma-
toid carcinoma using immunohistochemistry. Pathol Int 58:75–83.
10. Mutsaers SE: 2002, Mesothelial cells: their structure, function 
and role in serosal repair. Respirology 7:171–191.
11. Mutsaers SE: 2004, The mesothelial cell. Int J Biochem Cell 
Biol 36:9–16.
12. Raflo CP, Nuernberger SP: 1978, Abdominal mesothelioma in 
a cat. Vet Pathol 15:781–783.
13. Spugnini EP, Crispi S, Scarabello A, et al.: 2008, Piroxicam and 
intracavitary platinum-based chemotherapy for the treatment 
of advanced mesothelioma in pets: preliminary observations. J 
Exp Clin Cancer Res 27:6.
14. Suster S, Moran CA: 2006, Applications and limitations of 
immunohistochemistry in the diagnosis of malignant mesothe-
lioma. Adv Anat Pathol 13:316–329.
15. Withrow SJ, Vail DM: 2006, Miscellaneous tumors. In: Withrow 
and MacEwen’s small animal clinical oncology, ed. Withrow SJ, 
Vail DM, 4th ed., pp. 804–808. Saunders, St. Louis, MO.
16. Yung S, Li FK, Chan TM: 2006, Peritoneal mesothelial cell 
culture and biology. Perit Dial Int 26:162–173.
